ACE and hypertensive disorder: Physicians from both groups agreed with evidence-based guidelines suggesting that patients with complicated hypertension (i.e., patients with diabetes, renal or cardiac disease) should be started on an angiotensin converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker (ARB) to ensure the required cardiovascular or renal protection.